Related references
Note: Only part of the references are listed.A Class of FeIII Macrocyclic Complexes with Alcohol Donor Groups as Effective T1 MRI Contrast Agents
Eric M. Snyder et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Dose Finding Study of Gadopiclenol, a New Macrocyclic Contrast Agent, in MRI of Central Nervous System
Martin Bendszus et al.
INVESTIGATIVE RADIOLOGY (2020)
Signal Enhancement and Enhancement Kinetics of Gadobutrol, Gadoteridol, and Gadoterate Meglumine in Various Body Regions A Comparative Animal Study
Gesine Knobloch et al.
INVESTIGATIVE RADIOLOGY (2020)
New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions
Jean-Christophe Brisset et al.
JOURNAL OF NEURORADIOLOGY (2020)
Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model
Philippe Robert et al.
RADIOLOGY (2020)
Next-Generation MRI Contrast Agents: Still Including Gadolinium
Michael F. Tweedle
RADIOLOGY (2020)
Modulating the Properties of Fe(III) Macrocyclic MRI Contrast Agents by Appending Sulfonate or Hydroxyl Groups
Didar Asik et al.
MOLECULES (2020)
Is Small Fiber Neuropathy Induced by Gadolinium-Based Contrast Agents?
Alexander Radbruch et al.
INVESTIGATIVE RADIOLOGY (2020)
Physicochemical and Pharmacokinetic Profiles of Gadopiclenol A New Macrocyclic Gadolinium Chelate With High T1 Relaxivity
Caroline Robic et al.
INVESTIGATIVE RADIOLOGY (2019)
Gadolinium-Based MRI Contrast Agents Induce Mitochondrial Toxicity and Cell Death in Human Neurons, and Toxicity Increases With Reduced Kinetic Stability of the Agent
Danielle V. Bower et al.
INVESTIGATIVE RADIOLOGY (2019)
Gadolinium Deposition in the Brain in a Large Animal Model Comparison of Linear and Macrocyclic Gadolinium-Based Contrast Agents
Alexander Radbruch et al.
INVESTIGATIVE RADIOLOGY (2019)
Glymphatic Pathway of Gadolinium-Based Contrast Agents Through the Brain Overlooked and Misinterpreted
Katerina Deike-Hofmann et al.
INVESTIGATIVE RADIOLOGY (2019)
A Manganese-based Alternative to Gadolinium: Contrast-enhanced MR Angiography, Excretion, Pharmacokinetics, and Metabolism
Eric M. Gale et al.
RADIOLOGY (2018)
Low-Molecular-Weight Iron Chelates May Be an Alternative to Gadolinium-based Contrast Agents for T1-weighted Contrast-enhanced MR Imaging
Philipp Boehm-Sturm et al.
RADIOLOGY (2018)
Manganese-Based Contrast Agents for Magnetic Resonance Imaging of Liver Tumors: Structure-Activity Relationships and Lead Candidate Evaluation
Junfeng Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents Comparative Study in Rats
Thomas Frenzel et al.
INVESTIGATIVE RADIOLOGY (2017)
Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates
Robert J. McDonald et al.
RADIOLOGY (2017)
A Manganese Alternative to Gadolinium for MRI Contrast
Eric M. Gale et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy
Tomonori Kanda et al.
RADIOLOGY (2015)
Synthesis and in vitro phantom NMR and MRI studies of fully organic free radicals, TEEPO-glucose and TEMPO-glucose, potential contrast agents for MRI
M. Soikkeli et al.
RSC ADVANCES (2015)
Emerging Applications for Ferumoxytol as a Contrast Agent in MRI
Mustafa R. Bashir et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2015)
High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-weighted MR Images: Relationship with Increasing Cumulative Dose of a Gadolinium-based Contrast Material
Tomonori Kanda et al.
RADIOLOGY (2014)
Gd loading by hypotonic swelling: an efficient and safe route for cellular labeling
Enza Di Gregorio et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2013)
MRI contrast agents: Basic chemistry and safety
Dapeng Hao et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2012)
Synthesis and Reduction Kinetics of Sterically Shielded Pyrrolidine Nitroxides
Joseph T. Paletta et al.
ORGANIC LETTERS (2012)
Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging
Peter Marckmann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
T Grobner
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative-to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy
GW White et al.
INVESTIGATIVE RADIOLOGY (2006)
The cost of developing imaging agents for routine clinical use
AD Nunn
INVESTIGATIVE RADIOLOGY (2006)
Synthesis of two 3,5-disubstituted sulfonamide catechol ligands and evaluation of their iron(III) complexes for use as MRI contrast agents
DD Schwert et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Pharmacokinetics and safety of gadobenate dimeglumine (Multihance) in subjects with impaired liver function
BE Davies et al.
INVESTIGATIVE RADIOLOGY (2002)
Share Paper
